The hepatocyte growth factor (HGF)-MET receptor tyrosine kinase signaling pathway: Diverse roles in modulating immune cell functions

Cytokine

Volumn 82, Issue , 2016, Pages 125-139

  Ilangumaran, Subburaj ^a   Villalobos Hernandez, Alberto ^a   Bobbala, Diwakar ^a   Ramanathan, Sheela ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

B lymphocyte; Dendritic cell; Hematopoiesis; HGF; Macrophage; MET; Neutrophils; T lymphocyte

Indexed keywords

MESSENGER RNA; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SEMAPHORIN; HGF PROTEIN, HUMAN; MET PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MIGRATION; CELL SURVIVAL; CHRONIC GRAFT VERSUS HOST DISEASE; CYTOKINE PRODUCTION; DENDRITIC CELL; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HOMEOSTASIS; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; LANGERHANS CELL; LYMPHOCYTE ACTIVATION; MACROPHAGE; MOLECULAR DOCKING; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; ANIMAL; CELL MOTION; IMMUNOLOGY; MOUSE; T LYMPHOCYTE;

ADAPTIVE IMMUNITY; ANIMALS; B-LYMPHOCYTES; CELL MOVEMENT; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HEPATOCYTE GROWTH FACTOR; HUMANS; MICE; PROTO-ONCOGENE PROTEINS C-MET; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84955572594     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.12.013     Document Type: Article

References (210)

1. Nakamura T., Nawa K., Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem. Biophys. Res. Commun. 1984, 122:1450-1459.
2. Russell W.E., McGowan J.A., Bucher N.L. Partial characterization of a hepatocyte growth factor from rat platelets. J. Cell. Physiol. 1984, 119:183-192.
3. Nakamura T., Nawa K., Ichihara A., Kaise N., Nishino T. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett. 1987, 224:311-316.
4. Gohda E., Tsubouchi H., Nakayama H., Hirono S., Sakiyama O., Takahashi K., et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J. Clin. Invest. 1988, 81:414-419.
5. Zarnegar R., Michalopoulos G. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. Cancer Res. 1989, 49:3314-3320.
6. Stoker M., Gherardi E., Perryman M., Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 1987, 327:239-242.
7. Miyazawa K., Tsubouchi H., Naka D., Takahashi K., Okigaki M., Arakaki N., et al. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem. Biophys. Res. Commun. 1989, 163:967-973.
8. Nakamura T., Nishizawa T., Hagiya M., Seki T., Shimonishi M., Sugimura A., et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989, 342:440-443.
9. Montesano R., Matsumoto K., Nakamura T., Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 1991, 67:901-908.
10. Weidner K.M., Arakaki N., Hartmann G., Vandekerckhove J., Weingart S., Rieder H., et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc. Natl. Acad. Sci. USA 1991, 88:7001-7005.
11. Bottaro D.P., Rubin J.S., Faletto D.L., Chan A.M., Kmiecik T.E., Vande Woude G.F., et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991, 251:802-804.
12. Naldini L., Vigna E., Narsimhan R.P., Gaudino G., Zarnegar R., Michalopoulos G.K., et al. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene 1991, 6:501-504.
13. Nakamura T., Sakai K., Nakamura T., Matsumoto K. Hepatocyte growth factor twenty years on: much more than a growth factor. J. Gastroenterol. Hepatol. 2011, 26(Suppl 1):188-202.
14. Park M., Dean M., Cooper C.S., Schmidt M., O'Brien S.J., Blair D.G., et al. Mechanism of met oncogene activation. Cell 1986, 45:895-904.
15. Birchmeier C., Birchmeier W., Gherardi E., Vande Woude G.F. Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 2003, 4:915-925.
16. Benvenuti S., Comoglio P.M. The MET receptor tyrosine kinase in invasion and metastasis. J. Cell. Physiol. 2007, 213:316-325.
17. Knudsen B.S., Vande Woude G. Showering c-MET-dependent cancers with drugs. Curr. Opin. Genet. Dev. 2008, 18:87-96.
18. Gherardi E., Birchmeier W., Birchmeier C., Vande Woude G. Targeting MET in cancer: rationale and progress. Nat. Rev. Cancer 2012, 12:89-103.
19. Comoglio P.M., Giordano S., Trusolino L. Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat. Rev. 2008, 7:504-516.
20. Trusolino L., Bertotti A., Comoglio P.M. MET signalling: principles and functions in development, organ regeneration and cancer. Nat. Rev. Mol. Cell Biol. 2010, 11:834-848.
21. Sakai K., Aoki S., Matsumoto K. Hepatocyte growth factor and Met in drug discovery. J. Biochem. 2015, 157:271-284.
22. Tamagnone L., Comoglio P.M. Control of invasive growth by hepatocyte growth factor (HGF) and related scatter factors. Cytokine Growth Factor Rev. 1997, 8:129-142.
23. Donate L.E., Gherardi E., Srinivasan N., Sowdhamini R., Aparicio S., Blundell T.L. Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP). Protein Sci. 1994, 3:2378-2394.
24. Kobayashi T., Honke K., Miyazaki T., Matsumoto K., Nakamura T., Ishizuka I., et al. Hepatocyte growth factor specifically binds to sulfoglycolipids. J. Biol. Chem. 1994, 269:9817-9821.
25. Taipale J., Keski-Oja J. Growth factors in the extracellular matrix. FASEB J. 1997, 11:51-59.
26. Matsumoto K., Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J. Biochem. 1996, 119:591-600.
27. Miyazawa K., Shimomura T., Kitamura A., Kondo J., Morimoto Y., Kitamura N. Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII. J. Biol. Chem. 1993, 268:10024-10028.
28. Lee S.L., Dickson R.B., Lin C.Y. Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J. Biol. Chem. 2000, 275:36720-36725.
29. Herter S., Piper D.E., Aaron W., Gabriele T., Cutler G., Cao P., et al. Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers. Biochem J. 2005, 390:125-136.
30. Kataoka H., Kawaguchi M. Hepatocyte growth factor activator (HGFA): pathophysiological functions in vivo. FEBS J. 2010, 277:2230-2237.
31. Fukuta K., Matsumoto K., Nakamura T. Multiple biological responses are induced by glycosylation-deficient hepatocyte growth factor. Biochem J. 2005, 388:555-562.
32. Matsumoto K., Kataoka H., Date K., Nakamura T. Cooperative interaction between alpha- and beta-chains of hepatocyte growth factor on c-Met receptor confers ligand-induced receptor tyrosine phosphorylation and multiple biological responses. J. Biol. Chem. 1998, 273:22913-22920.
33. Matsumoto K., Tajima H., Hamanoue M., Kohno S., Kinoshita T., Nakamura T. Identification and characterization of "injurin," an inducer of expression of the gene for hepatocyte growth factor. Proc. Natl. Acad. Sci. USA 1992, 89:3800-3804.
34. Hu Z., Evarts R.P., Fujio K., Marsden E.R., Thorgeirsson S.S. Expression of hepatocyte growth factor and c-met genes during hepatic differentiation and liver development in the rat. Am. J. Pathol. 1993, 142:1823-1830.
35. Nagaike M., Hirao S., Tajima H., Noji S., Taniguchi S., Matsumoto K., et al. Renotropic functions of hepatocyte growth factor in renal regeneration after unilateral nephrectomy. J. Biol. Chem. 1991, 266:22781-22784.
36. Noji S., Tashiro K., Koyama E., Nohno T., Ohyama K., Taniguchi S., et al. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem. Biophys. Res. Commun. 1990, 173:42-47.
37. Schirmacher P., Geerts A., Pietrangelo A., Dienes H.P., Rogler C.E. Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells. Hepatology 1992, 15:5-11.
38. Maher J.J. Cell-specific expression of hepatocyte growth factor in liver. Upregulation in sinusoidal endothelial cells after carbon tetrachloride. J. Clin. Invest. 1993, 91:2244-2252.
39. Armbrust T., Batusic D., Xia L., Ramadori G. Early gene expression of hepatocyte growth factor in mononuclear phagocytes of rat liver after administration of carbon tetrachloride. Liver 2002, 22:486-494.
40. Kono S., Nagaike M., Matsumoto K., Nakamura T. Marked induction of hepatocyte growth factor mRNA in intact kidney and spleen in response to injury of distant organs. Biochem. Biophys. Res. Commun. 1992, 186:991-998.
41. Yanagita K., Nagaike M., Ishibashi H., Niho Y., Matsumoto K., Nakamura T. Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem. Biophys. Res. Commun. 1992, 182:802-809.
42. Suzuki S., Yamanouchi K., Soeta C., Katakai Y., Harada R., Naito K., et al. Skeletal muscle injury induces hepatocyte growth factor expression in spleen. Biochem. Biophys. Res. Commun. 2002, 292:709-714.
43. Zarnegar R., Michalopoulos G.K. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J. Cell Biol. 1995, 129:1177-1180.
44. Tolbert W.D., Daugherty-Holtrop J., Gherardi E., Vande Woude G., Xu H.E. Structural basis for agonism and antagonism of hepatocyte growth factor. Proc. Natl. Acad. Sci. USA 2010, 107:13264-13269.
45. Pavone L.M., Cattaneo F., Rea S., De Pasquale V., Spina A., Sauchelli E., et al. Intracellular signaling cascades triggered by the NK1 fragment of hepatocyte growth factor in human prostate epithelial cell line PNT1A. Cell. Signal. 2011, 23:1961-1971.
46. Kuba K., Matsumoto K., Date K., Shimura H., Tanaka M., Nakamura T. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Cancer Res. 2000, 60:6737-6743.
47. Cooper C.S., Park M., Blair D.G., Tainsky M.A., Huebner K., Croce C.M., et al. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 1984, 311:29-33.
48. Park M., Dean M., Kaul K., Braun M.J., Gonda M.A., Vande Woude G. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc. Natl. Acad. Sci. USA 1987, 84:6379-6383.
49. Giordano S., Ponzetto C., Di Renzo M.F., Cooper C.S., Comoglio P.M. Tyrosine kinase receptor indistinguishable from the c-met protein. Nature 1989, 339:155-156.
50. Robinson D.R., Wu Y.M., Lin S.F. The protein tyrosine kinase family of the human genome. Oncogene 2000, 19:5548-5557.
51. Giordano S., Di Renzo M.F., Narsimhan R.P., Cooper C.S., Rosa C., Comoglio P.M. Biosynthesis of the protein encoded by the c-met proto-oncogene. Oncogene 1989, 4:1383-1388.
52. Bardelli A., Ponzetto C., Comoglio P.M. Identification of functional domains in the hepatocyte growth factor and its receptor by molecular engineering. J. Biotechnol. 1994, 37:109-122.
53. Stamos J., Lazarus R.A., Yao X., Kirchhofer D., Wiesmann C. Crystal structure of the HGF beta-chain in complex with the Sema domain of the Met receptor. EMBO J. 2004, 23:2325-2335.
54. Komada M., Hatsuzawa K., Shibamoto S., Ito F., Nakayama K., Kitamura N. Proteolytic processing of the hepatocyte growth factor/scatter factor receptor by furin. FEBS Lett. 1993, 328:25-29.
55. Iyer A., Kmiecik T.E., Park M., Daar I., Blair D., Dunn K.J., et al. Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene. Cell Growth Differ. 1990, 1:87-95.
56. Prat M., Narsimhan R.P., Crepaldi T., Nicotra M.R., Natali P.G., Comoglio P.M. The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int. J. Cancer 1991, 49:323-328.
57. Di Renzo M.F., Narsimhan R.P., Olivero M., Bretti S., Giordano S., Medico E., et al. Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene 1991, 6:1997-2003.
58. Sonnenberg E., Meyer D., Weidner K.M., Birchmeier C. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J. Cell Biol. 1993, 123:223-235.
59. Nishino T., Hisha H., Nishino N., Adachi M., Ikehara S. Hepatocyte growth factor as a hematopoietic regulator. Blood 1995, 85:3093-3100.
60. Birchmeier C., Gherardi E. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol. 1998, 8:404-410.
61. Rahimi N., Tremblay E., McAdam L., Park M., Schwall R., Elliott B. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma. Cell Growth Differ. 1996, 7:263-270.
62. Nishida S., Hirohashi Y., Torigoe T., Inoue R., Kitamura H., Tanaka T., et al. Prostate cancer stem-like cells/cancer-initiating cells have an autocrine system of hepatocyte growth factor. Cancer Sci. 2013, 104:431-436.
63. Xie Q., Bradley R., Kang L., Koeman J., Ascierto M.L., Worschech A., et al. Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma. Proc. Natl. Acad. Sci. USA 2012, 109:570-575.
64. Yi S., Tsao M.S. Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line. Neoplasia 2000, 2:226-234.
65. Uehara Y., Minowa O., Mori C., Shiota K., Kuno J., Noda T., et al. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 1995, 373:702-705.
66. Schmidt C., Bladt F., Goedecke S., Brinkmann V., Zschiesche W., Sharpe M., et al. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 1995, 373:699-702.
67. Bladt F., Riethmacher D., Isenmann S., Aguzzi A., Birchmeier C. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 1995, 376:768-771.
68. Huh C.G., Factor V.M., Sanchez A., Uchida K., Conner E.A., Thorgeirsson S.S. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc. Natl. Acad. Sci. USA 2004, 101:4477-4482.
69. Borowiak M., Garratt A.N., Wustefeld T., Strehle M., Trautwein C., Birchmeier C. Met provides essential signals for liver regeneration. Proc. Natl. Acad. Sci. USA 2004, 101:10608-10613.
70. Factor V.M., Seo D., Ishikawa T., Kaposi-Novak P., Marquardt J.U., Andersen J.B., et al. Loss of c-Met disrupts gene expression program required for G2/M progression during liver regeneration in mice. PLoS One 2010, 5:e12739.
71. Baek J.H., Birchmeier C., Zenke M., Hieronymus T. The HGF receptor/Met tyrosine kinase is a key regulator of dendritic cell migration in skin immunity. J. Immunol. 2012, 189:1699-1707.
72. Song Y., Su M., Panchatsharam P., Rood D., Lai L. C-Met signalling is required for efficient postnatal thymic regeneration and repair. Immunology 2015, 144:245-253.
73. Toschi L., Janne P.A. Single-agent and combination therapeutic strategies to inhibit hepatocyte growth factor/MET signaling in cancer. Clin. Cancer Res. 2008, 14:5941-5946.
74. Giordano S., Columbano A. Met as a therapeutic target in HCC: facts and hopes. J. Hepatol. 2014, 60:442-452.
75. Komarowska I., Coe D., Wang G., Haas R., Mauro C., Kishore M., et al. Hepatocyte growth factor receptor c-Met instructs T cell cardiotropism and promotes T cell migration to the heart via autocrine chemokine release. Immunity 2015, 42:1087-1099.
76. Bolanos-Garcia V.M. MET meet adaptors: functional and structural implications in downstream signalling mediated by the Met receptor. Mol. Cell. Biochem. 2005, 276:149-157.
77. Palka H.L., Park M., Tonks N.K. Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1. J. Biol. Chem. 2003, 278:5728-5735.
78. Machide M., Hashigasako A., Matsumoto K., Nakamura T. Contact inhibition of hepatocyte growth regulated by functional association of the c-Met/hepatocyte growth factor receptor and LAR protein-tyrosine phosphatase. J. Biol. Chem. 2006, 281:8765-8772.
79. Sangwan V., Paliouras G.N., Abella J.V., Dube N., Monast A., Tremblay M.L., et al. Regulation of the Met receptor-tyrosine kinase by the protein-tyrosine phosphatase 1B and T-cell phosphatase. J. Biol. Chem. 2008, 283:34374-34383.
80. Kermorgant S., Parker P.J. C-Met signalling: spatio-temporal decisions. Cell Cycle 2005, 4:352-355.
81. Kermorgant S., Zicha D., Parker P.J. PKC controls HGF-dependent c-Met traffic, signalling and cell migration. EMBO J. 2004, 23:3721-3734.
82. Kermorgant S., Parker P.J. Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation. J. Cell Biol. 2008, 182:855-863.
83. Abella J.V., Parachoniak C.A., Sangwan V., Park M. Dorsal ruffle microdomains potentiate Met receptor tyrosine kinase signaling and down-regulation. J. Biol. Chem. 2010, 285:24956-24967.
84. Abella J.V., Peschard P., Naujokas M.A., Lin T., Saucier C., Urbe S., et al. Met/hepatocyte growth factor receptor ubiquitination suppresses transformation and is required for Hrs phosphorylation. Mol. Cell. Biol. 2005, 25:9632-9645.
85. Peschard P., Park M. From Tpr-Met to Met, tumorigenesis and tubes. Oncogene 2007, 26:1276-1285.
86. Jeffers M., Taylor G.A., Weidner K.M., Omura S., Vande Woude G.F. Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway. Mol. Cell. Biol. 1997, 17:799-808.
87. Hammond D.E., Urbe S., Vande Woude G.F., Clague M.J. Down-regulation of MET, the receptor for hepatocyte growth factor. Oncogene 2001, 20:2761-2770.
88. Foveau B., Ancot F., Leroy C., Petrelli A., Reiss K., Vingtdeux V., et al. Down-regulation of the met receptor tyrosine kinase by presenilin-dependent regulated intramembrane proteolysis. Mol. Biol. Cell 2009, 20:2495-2507.
89. Gui Y., Yeganeh M., Donates Y.C., Tobelaim W.S., Chababi W., Mayhue M., et al. Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma. Oncogene 2015, 34:5718-5728.
90. Kmiecik T.E., Keller J.R., Rosen E., Vande Woude G.F. Hepatocyte growth factor is a synergistic factor for the growth of hematopoietic progenitor cells. Blood 1992, 80:2454-2457.
91. Galimi F., Bagnara G.P., Bonsi L., Cottone E., Follenzi A., Simeone A., et al. Hepatocyte growth factor induces proliferation and differentiation of multipotent and erythroid hemopoietic progenitors. J. Cell Biol. 1994, 127:1743-1754.
92. Takai K., Hara J., Matsumoto K., Hosoi G., Osugi Y., Tawa A., et al. Hepatocyte growth factor is constitutively produced by human bone marrow stromal cells and indirectly promotes hematopoiesis. Blood 1997, 89:1560-1565.
93. Matsuda-Hashii Y., Takai K., Ohta H., Fujisaki H., Tokimasa S., Osugi Y., et al. Hepatocyte growth factor plays roles in the induction and autocrine maintenance of bone marrow stromal cell IL-11, SDF-1 alpha, and stem cell factor. Exp. Hematol. 2004, 32:955-961.
94. Yu C.Z., Hisha H., Li Y., Lian Z., Nishino T., Toki J., et al. Stimulatory effects of hepatocyte growth factor on hemopoiesis of SCF/c-kit system-deficient mice. Stem Cells 1998, 16:66-77.
95. Broudy V.C. Stem cell factor and hematopoiesis. Blood 1997, 90:1345-1364.
96. Munugalavadla V., Kapur R. Role of c-Kit and erythropoietin receptor in erythropoiesis. Crit. Rev. Oncol. Hematol. 2005, 54:63-75.
97. Kuroiwa T., Kakishita E., Hamano T., Kataoka Y., Seto Y., Iwata N., et al. Hepatocyte growth factor ameliorates acute graft-versus-host disease and promotes hematopoietic function. J. Clin. Invest. 2001, 107:1365-1373.
98. Sugiura K., Taketani S., Yoshimura T., Nishino T., Nishino N., Fujisawa J., et al. Effect of hepatocyte growth factor on long term hematopoiesis of human progenitor cells in transgenic-severe combined immunodeficiency mice. Cytokine 2007, 37:218-226.
99. Kosone T., Takagi H., Horiguchi N., Toyoda M., Sohara N., Kakizaki S., et al. Hepatocyte growth factor accelerates thrombopoiesis in transgenic mice. Lab. Invest. 2007, 87:284-291.
100. Tesio M., Golan K., Corso S., Giordano S., Schajnovitz A., Vagima Y., et al. Enhanced c-Met activity promotes G-CSF-induced mobilization of hematopoietic progenitor cells via ROS signaling. Blood 2011, 117:419-428.
101. McKenna S.D., Chen F., Lai L., Goldschneider I. Identification of an IL-7-associated pre-pro-B cell growth-stimulating factor (PPBSF). I. Production of the non-IL-7 component by bone marrow stromal cells from IL-7 gene-deleted mice. J. Immunol. 1998, 160:2272-2279.
102. Lai L., Chen F., McKenna S., Goldschneider I. Identification of an IL-7-associated pre-pro-B cell growth-stimulating factor (PPBSF). II. PPBSF is a covalently linked heterodimer of IL-7 and a Mr 30,000 cofactor. J. Immunol. 1998, 160:2280-2286.
103. Lai L., Goldschneider I. Cutting edge: identification of a hybrid cytokine consisting of IL-7 and the beta-chain of the hepatocyte growth factor/scatter factor. J. Immunol. 2001, 167:3550-3554.
104. Lai L., Zeff R.A., Goldschneider I. A recombinant single-chain IL-7/HGFbeta hybrid cytokine induces juxtacrine interactions of the IL-7 and HGF (c-Met) receptors and stimulates the proliferation of CFU-S12, CLPs, and pre-pro-B cells. Blood 2006, 107:1776-1784.
105. Lai L., Zhang M., Goldschneider I. Recombinant IL-7/HGFbeta efficiently induces transplantable murine hematopoietic stem cells. J. Clin. Invest. 2012, 122:3552-3562.
106. Takeda S., Liu H., Sasagawa S., Dong Y., Trainor P.A., Cheng E.H., et al. HGF-MET signals via the MLL-ETS2 complex in hepatocellular carcinoma. J. Clin. Invest. 2013, 123:3154-3165.
107. Mantovani A., Cassatella M.A., Costantini C., Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 2011, 11:519-531.
108. Mine S., Tanaka Y., Suematu M., Aso M., Fujisaki T., Yamada S., et al. Hepatocyte growth factor is a potent trigger of neutrophil adhesion through rapid activation of lymphocyte function-associated antigen-1. Lab. Invest. 1998, 78:1395-1404.
109. McCourt M., Wang J.H., Sookhai S., Redmond H.P. Activated human neutrophils release hepatocyte growth factor/scatter factor. Eur. J. Surg. Oncol. 2001, 27:396-403.
110. Crestani B., Dehoux M., Hayem G., Lecon V., Hochedez F., Marchal J., et al. Differential role of neutrophils and alveolar macrophages in hepatocyte growth factor production in pulmonary fibrosis. Lab. Invest. 2002, 82:1015-1022.
111. Grenier A., Chollet-Martin S., Crestani B., Delarche C., El Benna J., Boutten A., et al. Presence of a mobilizable intracellular pool of hepatocyte growth factor in human polymorphonuclear neutrophils. Blood 2002, 99:2997-3004.
112. Taieb J., Delarche C., Paradis V., Mathurin P., Grenier A., Crestani B., et al. Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitis. J. Hepatol. 2002, 36:342-348.
113. Jaffre S., Dehoux M., Paugam C., Grenier A., Chollet-Martin S., Stern J.B., et al. Hepatocyte growth factor is produced by blood and alveolar neutrophils in acute respiratory failure. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 282:L310-L315.
114. Fujii K., Ishimaru F., Kozuka T., Matsuo K., Nakase K., Kataoka I., et al. Elevation of serum hepatocyte growth factor during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization. Br. J. Haematol. 2004, 124:190-194.
115. Fridlender Z.G., Albelda S.M. Tumor-associated neutrophils: friend or foe?. Carcinogenesis 2012, 33:949-955.
116. Wislez M., Rabbe N., Marchal J., Milleron B., Crestani B., Mayaud C., et al. Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death. Cancer Res. 2003, 63:1405-1412.
117. Finisguerra V., Di Conza G., Di Matteo M., Serneels J., Costa S., Thompson A.A., et al. MET is required for the recruitment of anti-tumoural neutrophils. Nature 2015, 522:349-353.
118. Ginhoux F., Jung S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat. Rev. Immunol. 2014, 14:392-404.
119. Wynn T.A., Chawla A., Pollard J.W. Macrophage biology in development, homeostasis and disease. Nature 2013, 496:445-455.
120. Noy R., Pollard J.W. Tumor-associated macrophages: from mechanisms to therapy. Immunity 2014, 41:49-61.
121. Erblich B., Zhu L., Etgen A.M., Dobrenis K., Pollard J.W. Absence of colony stimulation factor-1 receptor results in loss of microglia, disrupted brain development and olfactory deficits. PLoS One 2011, 6:e26317.
122. Wang Y., Szretter K.J., Vermi W., Gilfillan S., Rossini C., Cella M., et al. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat. Immunol. 2012, 13:753-760.
123. Moghul A., Lin L., Beedle A., Kanbour-Shakir A., DeFrances M.C., Liu Y., et al. Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-MET transcript. Oncogene 1994, 9:2045-2052.
124. Chen Q., DeFrances M.C., Zarnegar R. Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation. Cell Growth Differ. 1996, 7:821-832.
125. Beilmann M., Odenthal M., Jung W., Vande Woude G.F., Dienes H.P., Schirmacher P. Neoexpression of the c-met/hepatocyte growth factor-scatter factor receptor gene in activated monocytes. Blood 1997, 90:4450-4458.
126. Beilmann M., Vande Woude G.F., Dienes H.P., Schirmacher P. Hepatocyte growth factor-stimulated invasiveness of monocytes. Blood 2000, 95:3964-3969.
127. Naldini L., Vigna E., Bardelli A., Follenzi A., Galimi F., Comoglio P.M. Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction. J. Biol. Chem. 1995, 270:603-611.
128. Galimi F., Cottone E., Vigna E., Arena N., Boccaccio C., Giordano S., et al. Hepatocyte growth factor is a regulator of monocyte-macrophage function. J. Immunol. 2001, 166:1241-1247.
129. Jiang Q., Azuma E., Tanaka M., Kobayashi M., Hirayama M., Kumamoto T., et al. Differential responsiveness of cord and adult blood monocytes to hepatocyte growth factor. Clin. Exp. Immunol. 2001, 125:222-228.
130. Morimoto K., Amano H., Sonoda F., Baba M., Senba M., Yoshimine H., et al. Alveolar macrophages that phagocytose apoptotic neutrophils produce hepatocyte growth factor during bacterial pneumonia in mice. Am. J. Respir. Cell Mol. Biol. 2001, 24:608-615.
131. Xing Z., Gauldie J., Cox G., Baumann H., Jordana M., Lei X.F., et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 1998, 101:311-320.
132. Coudriet G.M., He J., Trucco M., Mars W.M., Piganelli J.D. Hepatocyte growth factor modulates interleukin-6 production in bone marrow derived macrophages: implications for inflammatory mediated diseases. PLoS One 2010, 5:e15384.
133. Flaquer M., Franquesa M., Vidal A., Bolanos N., Torras J., Lloberas N., et al. Hepatocyte growth factor gene therapy enhances infiltration of macrophages and may induce kidney repair in db/db mice as a model of diabetes. Diabetologia 2012, 55:2059-2068.
134. Molnarfi N., Benkhoucha M., Bjarnadottir K., Juillard C., Lalive P.H. Interferon-beta induces hepatocyte growth factor in monocytes of multiple sclerosis patients. PLoS One 2012, 7:e49882.
135. Lalive P.H., Paglinawan R., Biollaz G., Kappos E.A., Leone D.P., Malipiero U., et al. TGF-beta-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway. Eur. J. Immunol. 2005, 35:727-737.
136. McNelis J.C., Olefsky J.M. Macrophages, immunity, and metabolic disease. Immunity 2014, 41:36-48.
137. Kusunoki H., Taniyama Y., Otsu R., Rakugi H., Morishita R. Anti-inflammatory effects of hepatocyte growth factor on the vicious cycle of macrophages and adipocytes. Hypertens. Res. 2014, 37:500-506.
138. Rehman J., Considine R.V., Bovenkerk J.E., Li J., Slavens C.A., Jones R.M., et al. Obesity is associated with increased levels of circulating hepatocyte growth factor. J. Am. Coll. Cardiol. 2003, 41:1408-1413.
139. Bell L.N., Ward J.L., Degawa-Yamauchi M., Bovenkerk J.E., Jones R., Cacucci B.M., et al. Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity. Am. J. Physiol. Endocrinol. Metab. 2006, 291:E843-E848.
140. Fafalios A., Ma J., Tan X., Stoops J., Luo J., Defrances M.C., et al. A hepatocyte growth factor receptor (Met)-insulin receptor hybrid governs hepatic glucose metabolism. Nat. Med. 2011, 17:1577-1584.
141. Araujo T.G., Oliveira A.G., Carvalho B.M., Guadagnini D., Protzek A.O., Carvalheira J.B., et al. Hepatocyte growth factor plays a key role in insulin resistance-associated compensatory mechanisms. Endocrinology 2012, 153:5760-5769.
142. Nombela-Arrieta C., Ritz J., Silberstein L.E. The elusive nature and function of mesenchymal stem cells. Nat. Rev. Mol. Cell Biol. 2011, 12:126-131.
143. Ma S., Xie N., Li W., Yuan B., Shi Y., Wang Y. Immunobiology of mesenchymal stem cells. Cell Death Differ. 2014, 21:216-225.
144. Chen P.M., Liu K.J., Hsu P.J., Wei C.F., Bai C.H., Ho L.J., et al. Induction of immunomodulatory monocytes by human mesenchymal stem cell-derived hepatocyte growth factor through ERK1/2. J. Leukoc. Biol. 2014, 96:295-303.
145. Wei X., Yang X., Han Z.P., Qu F.F., Shao L., Shi Y.F. Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol. Sin. 2013, 34:747-754.
146. Vogel S., Borger V., Peters C., Forster M., Liebfried P., Metzger K., et al. Necrotic cell-derived high mobility group box 1 attracts antigen-presenting cells but inhibits hepatocyte growth factor-mediated tropism of mesenchymal stem cells for apoptotic cell death. Cell Death Differ. 2015, 22:1219-1230.
147. Satpathy A.T., Wu X., Albring J.C., Murphy K.M. Re(de)fining the dendritic cell lineage. Nat. Immunol. 2012, 13:1145-1154.
148. Merad M., Sathe P., Helft J., Miller J., Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 2013, 31:563-604.
149. Ganguly D., Haak S., Sisirak V., Reizis B. The role of dendritic cells in autoimmunity. Nat. Rev. Immunol. 2013, 13:566-577.
150. Kurz S.M., Diebold S.S., Hieronymus T., Gust T.C., Bartunek P., Sachs M., et al. The impact of c-met/scatter factor receptor on dendritic cell migration. Eur. J. Immunol. 2002, 32:1832-1838.
151. Hieronymus T., Zenke M., Baek J.H., Sere K. The clash of Langerhans cell homeostasis in skin: should I stay or should I go?. Semin. Cell Dev. Biol. 2015, 41:30-38.
152. Price A.A., Cumberbatch M., Kimber I., Ager A. Alpha 6 integrins are required for Langerhans cell migration from the epidermis. J. Exp. Med. 1997, 186:1725-1735.
153. Trusolino L., Bertotti A., Comoglio P.M. A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth. Cell 2001, 107:643-654.
154. Stewart R.L., O'Connor K.L. Clinical significance of the integrin alpha6beta4 in human malignancies. Lab. Invest. 2015, 95:976-986.
155. Okunishi K., Dohi M., Nakagome K., Tanaka R., Mizuno S., Matsumoto K., et al. A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J. Immunol. 2005, 175:4745-4753.
156. Shortman K., Liu Y.J. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2002, 2:151-161.
157. Rutella S., Bonanno G., Procoli A., Mariotti A., de Ritis D.G., Curti A., et al. Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features. Blood 2006, 108:218-227.
158. Benkhoucha M., Santiago-Raber M.L., Schneiter G., Chofflon M., Funakoshi H., Nakamura T., et al. Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 2010, 107:6424-6429.
159. Baxter A.G. The origin and application of experimental autoimmune encephalomyelitis. Nat. Rev. Immunol. 2007, 7:904-912.
160. Constantinescu C.S., Farooqi N., O'Brien K., Gran B. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br. J. Pharmacol. 2011, 164:1079-1106.
161. Yamaura K., Ito K., Tsukioka K., Wada Y., Makiuchi A., Sakaguchi M., et al. Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: induction of tolerance and prevention of cardiac allograft vasculopathy. Circulation 2004, 110:1650-1657.
162. Futamatsu H., Suzuki J., Mizuno S., Koga N., Adachi S., Kosuge H., et al. Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis: a potential role for induction of T helper 2 cytokines. Circ. Res. 2005, 96:823-830.
163. Benkhoucha M., Molnarfi N., Dunand-Sauthier I., Merkler D., Schneiter G., Bruscoli S., et al. Hepatocyte growth factor limits autoimmune neuroinflammation via glucocorticoid-induced leucine zipper expression in dendritic cells. J. Immunol. 2014, 193:2743-2752.
164. Singhal E., Sen P. Hepatocyte growth factor-induced c-Src-phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway inhibits dendritic cell activation by blocking IkappaB kinase activity. Int. J. Biochem. Cell Biol. 2011, 43:1134-1146.
165. Weaver D.J., Poligone B., Bui T., Abdel-Motal U.M., Baldwin A.S., Tisch R. Dendritic cells from nonobese diabetic mice exhibit a defect in NF-kappa B regulation due to a hyperactive I kappa B kinase. J. Immunol. 2001, 167:1461-1468.
166. Rescigno M., Martino M., Sutherland C.L., Gold M.R., Ricciardi-Castagnoli P. Dendritic cell survival and maturation are regulated by different signaling pathways. J. Exp. Med. 1998, 188:2175-2180.
167. Singhal E., Kumar P., Sen P. A novel role for Bruton's tyrosine kinase in hepatocyte growth factor-mediated immunoregulation of dendritic cells. J. Biol. Chem. 2011, 286:32054-32063.
168. Berrebi D., Bruscoli S., Cohen N., Foussat A., Migliorati G., Bouchet-Delbos L., et al. Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. Blood 2003, 101:729-738.
169. Motz G.T., Coukos G. Deciphering and reversing tumor immune suppression. Immunity 2013, 39:61-73.
170. Xu A.M., Huang P.H. Receptor tyrosine kinase coactivation networks in cancer. Cancer Res. 2010, 70:3857-3860.
171. Gui Y., Yeganeh M., Cepero-Donates Y., Ramanathan S., Saucier C., Ilangumaran S. Regulation of MET receptor signaling by SOCS1 and its implications for hepatocellular carcinoma. Curr. Pharm. Des. 2014, 20:2922-2933.
172. Yu G., Jing Y., Kou X., Ye F., Gao L., Fan Q., et al. Hepatic stellate cells secreted hepatocyte growth factor contributes to the chemoresistance of hepatocellular carcinoma. PLoS One 2013, 8:e73312.
173. Jia C.C., Wang T.T., Liu W., Fu B.S., Hua X., Wang G.Y., et al. Cancer-associated fibroblasts from hepatocellular carcinoma promote malignant cell proliferation by HGF secretion. PLoS One 2013, 8:e63243.
174. Straussman R., Morikawa T., Shee K., Barzily-Rokni M., Qian Z.R., Du J., et al. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature 2012, 487:500-504.
175. Tamura S., Sugawara T., Tokoro Y., Taniguchi H., Fukao K., Nakauchi H., et al. Expression and function of c-Met, a receptor for hepatocyte growth factor, during T-cell development. Scand. J. Immunol. 1998, 47:296-301.
176. Blackburn C.C., Manley N.R. Developing a new paradigm for thymus organogenesis. Nat. Rev. Immunol. 2004, 4:278-289.
177. Jin J., Goldschneider I., Lai L. In vivo administration of the recombinant IL-7/hepatocyte growth factor beta hybrid cytokine efficiently restores thymopoiesis and naive T cell generation in lethally irradiated mice after syngeneic bone marrow transplantation. J. Immunol. 2011, 186:1915-1922.
178. Carrio R., Altman N.H., Lopez D.M. Downregulation of interleukin-7 and hepatocyte growth factor in the thymic microenvironment is associated with thymus involution in tumor-bearing mice. Cancer Immunol. Immunother. 2009, 58:2059-2072.
179. Skibinski G., Skibinska A., James K. The role of hepatocyte growth factor and its receptor c-met in interactions between lymphocytes and stromal cells in secondary human lymphoid organs. Immunology 2001, 102:506-514.
180. Carrio R., Lopez D.M. Insights into thymic involution in tumor-bearing mice. Immunol. Res. 2013, 57:106-114.
181. Imado T., Iwasaki T., Kataoka Y., Kuroiwa T., Hara H., Fujimoto J., et al. Hepatocyte growth factor preserves graft-versus-leukemia effect and T-cell reconstitution after marrow transplantation. Blood 2004, 104:1542-1549.
182. Lai L., Zhang M., Song Y., Rood D. Recombinant IL-7/HGFbeta hybrid cytokine enhances T cell recovery in mice following allogeneic bone marrow transplantation. PLoS One 2013, 8:e82998.
183. Lai L., Jin J., Hodio J., Goldschneider I. A human recombinant IL-7/HGFalpha hybrid cytokine enhances T-cell reconstitution in mice after syngeneic bone marrow transplantation. Transplantation 2011, 92:516-522.
184. Jung W.S., Han S.M., Kim S.M., Kim M.E., Lee J.S., Seo K.W., et al. Stimulatory effect of HGF-overexpressing adipose tissue-derived mesenchymal stem cells on thymus regeneration in a rat thymus involution model. Cell Biol. Int. 2014, 38:1106-1117.
185. Benkhoucha M., Molnarfi N., Schneiter G., Walker P.R., Lalive P.H. The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activity. J. Neuroinflammation 2013, 10:154.
186. Oku M., Okumi M., Shimizu A., Sahara H., Setoyama K., Nishimura H., et al. Hepatocyte growth factor sustains T regulatory cells and prolongs the survival of kidney allografts in major histocompatibility complex-inbred CLAWN-miniature swine. Transplantation 2012, 93:148-155.
187. Lai L., Jin J., Goldschneider I. In vivo antitumor activity of a recombinant IL-7/HGFbeta hybrid cytokine in mice. Cancer Res. 2011, 71:61-67.
188. Adams D.H., Harvath L., Bottaro D.P., Interrante R., Catalano G., Tanaka Y., et al. Hepatocyte growth factor and macrophage inflammatory protein 1 beta: structurally distinct cytokines that induce rapid cytoskeletal changes and subset-preferential migration in T cells. Proc. Natl. Acad. Sci. USA 1994, 91:7144-7148.
189. Wolf D., Li J., Ley K. HGF guides T cells into the heart. Immunity 2015, 42:979-981.
190. Delaney B., Kaminski N.E. Induction of serum borne immunomodulatory factors in B6C3F1 mice by carbon tetrachloride. Exposure to carbon tetrachloride produces an increase in B-cell number and function. Toxicology 1994, 88:201-212.
191. Lindroos P.M., Zarnegar R., Michalopoulos G.K. Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology 1991, 13:743-750.
192. Delaney B., Koh W.S., Yang K.H., Strom S.C., Kaminski N.E. Hepatocyte growth factor enhances B-cell activity. Life Sci. 1993, 53:PL89-PL93.
193. van der Voort R., Taher T.E., Keehnen R.M., Smit L., Groenink M., Pals S.T. Paracrine regulation of germinal center B cell adhesion through the c-met-hepatocyte growth factor/scatter factor pathway. J. Exp. Med. 1997, 185:2121-2131.
194. De Silva N.S., Klein U. Dynamics of B cells in germinal centres. Nat. Rev. Immunol. 2015, 15:137-148.
195. van Kooten C., Banchereau J. CD40-CD40 ligand. J. Leukoc. Biol. 2000, 67:2-17.
196. Lyon M., Deakin J.A., Mizuno K., Nakamura T., Gallagher J.T. Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants. J. Biol. Chem. 1994, 269:11216-11223.
197. Jackson D.G., Bell J.I., Dickinson R., Timans J., Shields J., Whittle N. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J. Cell Biol. 1995, 128:673-685.
198. Bennett K.L., Jackson D.G., Simon J.C., Tanczos E., Peach R., Modrell B., et al. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J. Cell Biol. 1995, 128:687-698.
199. van der Voort R., Taher T.E., Wielenga V.J., Spaargaren M., Prevo R., Smit L., et al. Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met. J. Biol. Chem. 1999, 274:6499-6506.
200. Zoller M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?. Nat. Rev. Cancer 2011, 11:254-267.
201. van der Voort R., Keehnen R.M., Beuling E.A., Spaargaren M., Pals S.T. Regulation of cytokine signaling by B cell antigen receptor and CD40-controlled expression of heparan sulfate proteoglycans. J. Exp. Med. 2000, 192:1115-1124.
202. Orian-Rousseau V., Chen L., Sleeman J.P., Herrlich P., Ponta H. CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev. 2002, 16:3074-3086.
203. Starlets D., Gore Y., Binsky I., Haran M., Harpaz N., Shvidel L., et al. Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival. Blood 2006, 107:4807-4816.
204. Gore Y., Starlets D., Maharshak N., Becker-Herman S., Kaneyuki U., Leng L., et al. Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex. J. Biol. Chem. 2008, 283:2784-2792.
205. Gordin M., Tesio M., Cohen S., Gore Y., Lantner F., Leng L., et al. C-Met and its ligand hepatocyte growth factor/scatter factor regulate mature B cell survival in a pathway induced by CD74. J. Immunol. 2010, 185:2020-2031.
206. Cohen S., Shoshana O.Y., Zelman-Toister E., Maharshak N., Binsky-Ehrenreich I., Gordin M., et al. The cytokine midkine and its receptor RPTPzeta regulate B cell survival in a pathway induced by CD74. J. Immunol. 2012, 188:259-269.
207. Muramatsu T. Structure and function of midkine as the basis of its pharmacological effects. Br. J. Pharmacol. 2014, 171:814-826.
208. Cohen S., Shachar I. Midkine as a regulator of B cell survival in health and disease. Br. J. Pharmacol. 2014, 171:888-895.
209. Mahtouk K., Tjin E.P., Spaargaren M., Pals S.T. The HGF/MET pathway as target for the treatment of multiple myeloma and B-cell lymphomas. Biochim. Biophys. Acta 2010, 1806:208-219.
210. Molnarfi N., Benkhoucha M., Funakoshi H., Nakamura T., Lalive P.H. Hepatocyte growth factor: a regulator of inflammation and autoimmunity. Autoimmun. Rev. 2015, 14:293-303.